Lipoclar

Lipoclar Brand names, Lipoclar Analogs

Lipoclar Brand Names Mixture

No information avaliable

Lipoclar Chemical_Formula

C₂₀H₂₁ClO₄

Lipoclar RX_link

http://www.rxlist.com/cgi/generic3/fenofibrate.htm

Lipoclar fda sheet

Lipoclar FDA

Lipoclar msds (material safety sheet)

Lipoclar MSDS

Lipoclar Synthesis Reference

No information avaliable

Lipoclar Molecular Weight

360.831 g/mol

Lipoclar Melting Point

80.5 °C

Lipoclar H₂O Solubility

0.25mg/ml at 25 °C

Lipoclar State

Solid

Lipoclar LogP

5.575

Lipoclar Dosage Forms

Capsule; Tablet

Lipoclar Indication

For use as adjunctive therapy to diet to reduce elevated LDL-C, Total-C,Triglycerides and Apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia (Fredrickson Types IIa and IIb)

Lipoclar Pharmacology

Fenofibrate is a lipid regulating agent indicated as adjunctive therapy to diet to reduce elevated LDL-C, Total-C,Triglycerides and Apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia (Fredrickson Types IIa and IIb). Fenofibrate is also indicated as adjunctive therapy to diet for treatment of adult patients with hypertriglyceridemia (Fredrickson Types IV and V hyperlipidemia). Fenofibric acid, the active metabolite of Fenofibrate, produces reductions in total cholesterol, LDL cholesterol, apolipoprotein B, total triglycerides and triglyceride rich lipoprotein (VLDL) in treated patients. In addition, treatment with fenofibrate results in increases in high density lipoprotein (HDL) and apoproteins apoAI and apoAII.

Lipoclar Absorption

Fenofibrate is well absorbed from the gastrointestinal tract. After absorption, fenofibrate is mainly excreted in the urine in the form of metabolites, primarily fenofibric acid and fenofibric acid glucuronide

Lipoclar side effects and Toxicity

LD₅₀=1600 mg/kg (Oral, in mice); Investigated as a teratogen and reproductive hazard.

Lipoclar Patient Information